Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma Article Early Access

Industry Collaboration

cited authors

  • Botta, Gregory P.; Abdelrahim, Maen; Drengler, Ronald L.; Aushev, Vasily N.; Esmail, Abdullah; Laliotis, George; Brewer, Chris M.; George, Giby, V; Abbate, Steven M.; Chandana, Sreenivasa R.; Tejani, Mohamedtaki A.; Malla, Midhun; Bansal, Dhruv; Rivero-Hinojosa, Samuel; Spickard, Erik; McCormick, Nicole; Cecchini, Michael; Lacy, Jill; Fei, Naomi; Kasi, Pashtoon Murtaza; Kasi, Anup; Dayyani, Farshid; Hanna, Diana L.; Sharma, Shruti; Malhotra, Meenakshi; Aleshin, Alexey; Liu, Minetta C.; Jurdi, Adham

Publication Date

  • July 17, 2024

webpage

published in

category

keywords

  • KRAS
  • ctDNA
  • molecular residual disease
  • pancreatic adenocarcinoma